Slapnicar, C. et al. 2026. Adriamycin, Vinblastine and Dacarbazine With Immunotherapy Achieves Complete Metabolic Response in a Patient With Classical Hodgkin Lymphoma and Dyskeratosis Congenita. Journal of Hematology. 15, 2 (Jan. 2026), 129–134. DOI:https://doi.org/10.14740/jh2160.